REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka 258 AO (Аптека 258 АО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka 258 AO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Apteka 258 AO (Аптека 258 АО) is a company based in Russia, with its head office in Samara. It operates in the Pharmacies and Drug Stores industry. Apteka 258 AO (Аптека 258 АО) was incorporated on December 18, 2002. The total number of employees is currently 12 (2022). There was a net sales revenue drop of 3.72% reported in Apteka 258 AO (Аптека 258 АО)’s latest financial highlights for 2024. There was a total negative growth of 19.26% in Apteka 258 AO (Аптека 258 АО)’s total assets over the same period. The net profit margin of Apteka 258 AO (Аптека 258 АО) increased by 693.88% in 2024.

Headquarters
Maslennikova, 18, 27
Samara; Samara Oblast; Postal Code: 443056

Contact Details: Purchase the Apteka 258 AO (Аптека 258 АО) report to view the information.

Basic Information
Total Employees:
Purchase the Apteka 258 AO (Аптека 258 АО) report to view the information.
Registered Capital:
Purchase the Apteka 258 AO (Аптека 258 АО) report to view the information.
Financial Auditors:
Purchase the Apteka 258 AO (Аптека 258 АО) report to view the information.
Incorporation Date:
December 18, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka 258 AO (Аптека 258 АО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-3.72%
Total operating revenue
-3.72%
Operating profit (EBIT)
76.21%
Net Profit (Loss) for the Period
85.93%
Total Assets
-19.26%
Total Equity
-12.02%
Operating Profit Margin (ROS)
624.18%
Net Profit Margin
693.88%
Return on Equity (ROE)
71.78%
Quick Ratio
429.1%
Cash Ratio
40.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?